In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deals In Depth: October 2015

Executive Summary

BMS replaced and signed a new deal with Five Prime Therapeutics in immuno-oncology; there was more consolidation in the pharma services industry with Walgreens' $17.2 billion acquisition of Rite Aid. Biopharma financing in October was down from the previous month to $2.1 billion; device fundraising also decreased, to $468 million.

Advertisement

Topics

Related Companies

UsernamePublicRestriction

Register